Skip to main content

Featured

The CUSMA Countdown: 24 Days to a Trade Deadline That Could Hit Your Wallet

Canada's free trade deal with the U.S. hits a mandatory review milestone on July 1. With negotiations unresolved and Washington demanding changes, here's what it actually means for your groceries, your car, and your job. MoneySavings.ca Staff Canadian Money Brief June 7, 2026 5 min read What Is CUSMA and Why Does July 1 Matter? CUSMA — the Canada-United States-Mexico Agreement — is the trade deal that keeps the North American economy humming. It replaced NAFTA in 2020 and governs the movement of trillions of dollars in goods and services across the Canada-U.S. border every year. For Canadian consumers, it's largely invisible — until it isn't. Built into the agreement is a mandatory six-year joint review, and that clock expires on July 1, 2026 . By that date, all three countries must declare whether they want to renew the deal for another 16 years, trigger annual reviews, or walk away. Whatever they decide, CUSMA technically stays in force until 2036 — but the path chose...

article

Stock Market Today: Dow, S&P 500, Nasdaq Rebound Amid China Tariff Retaliation and New Jobs Data

                                    

US stocks rebounded on Tuesday as investors assessed China's swift retaliation to the latest US tariffs and digested fresh jobs data. The Dow Jones Industrial Average rose by 0.2%, while the S&P 500 gained 0.7%, and the tech-heavy Nasdaq Composite jumped 1.2%.

China responded to the new 10% tariffs imposed by the US with tariffs of its own on US coal, liquified natural gas, crude oil, farm equipment, and some autos. Despite the escalating trade tensions, some analysts see China's measured response as a potential opening for compromise.

Meanwhile, job openings in the US declined more than expected in December, adding to concerns about the labor market's cooling trend. Investors are closely watching these developments as the Federal Reserve considers future interest rate cuts amid ongoing inflation concerns.

Tech stocks led the gains, with Alphabet (Google) shares rising nearly 2% ahead of its fourth-quarter earnings report. Vaccine stocks, however, fell after Robert F. Kennedy Jr.'s nomination to lead the Health and Human Services Department advanced to the Senate.

Overall, the market's positive reaction suggests cautious optimism as traders navigate the complexities of trade relations and economic data.



Comments